Bosch, J., Harrison, S. A., Abdelmalek, M. F., Shiffman, M. L., Diehl, A. M., Caldwell, S. H., … Sanyal, A. J. (2017). Hepatic venous pressure gradient (HVPG) predicts clinical disease progression in patients with compensated cirrhosis due to NASH. In HEPATOLOGY (Vol. 66, pp. 244A-245A). Washington, DC: WILEY.

Bosch, Jaime, Stephen A. Harrison, Manal F. Abdelmalek, Mitchell L. Shiffman, Anna Mae Diehl, Stephen H. Caldwell, Don C. Rockey, et al. “Hepatic venous pressure gradient (HVPG) predicts clinical disease progression in patients with compensated cirrhosis due to NASH.” In HEPATOLOGY, 66:244A-245A. WILEY, 2017.

Bosch J, Harrison SA, Abdelmalek MF, Shiffman ML, Diehl AM, Caldwell SH, et al. Hepatic venous pressure gradient (HVPG) predicts clinical disease progression in patients with compensated cirrhosis due to NASH. In: HEPATOLOGY. WILEY; 2017. p. 244A-245A.

Bosch, Jaime, et al. “Hepatic venous pressure gradient (HVPG) predicts clinical disease progression in patients with compensated cirrhosis due to NASH.” HEPATOLOGY, vol. 66, WILEY, 2017, pp. 244A-245A.

Bosch J, Harrison SA, Abdelmalek MF, Shiffman ML, Diehl AM, Caldwell SH, Rockey DC, Ghalib R, Thuluvath PJ, Schall REA, Jia C, McColgan BJ, Myers RP, Subramanian M, McHutchison JG, Afdhal NH, Ratziu V, Goodman ZD, Sanyal AJ. Hepatic venous pressure gradient (HVPG) predicts clinical disease progression in patients with compensated cirrhosis due to NASH. HEPATOLOGY. WILEY; 2017. p. 244A-245A.